Article Versions Notes

Cruz AF, Caleiras MB, Fonseca NA, Gonçalves N, Mendes VM, Sampaio SF, Moura V, Melo JB, Almeida RD, Manadas B, et al. The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway. Cancers. 2021; 13(12):3052. https://doi.org/10.3390/cancers13123052

Cruz, Ana F., Mariana B. Caleiras, Nuno A. Fonseca, Nélio Gonçalves, Vera M. Mendes, Susana F. Sampaio, Vera Moura, Joana B. Melo, Ramiro D. Almeida, Bruno Manadas, and et al. 2021. "The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway" Cancers 13, no. 12: 3052. https://doi.org/10.3390/cancers13123052

Cruz, A. F., Caleiras, M. B., Fonseca, N. A., Gonçalves, N., Mendes, V. M., Sampaio, S. F., Moura, V., Melo, J. B., Almeida, R. D., Manadas, B., Simões, S., & Moreira, J. N. (2021). The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway. Cancers, 13(12), 3052. https://doi.org/10.3390/cancers13123052